GERMANTOWN, Md.--(BUSINESS WIRE)--Theraly Fibrosis, a preclinical-stage biotechnology company focused on development and commercialization of drugs for various fibrotic diseases today announced the ...
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis
LA JOLLA, Calif., April 24, 2024 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated ...
DUBLIN--(BUSINESS WIRE)--The "Pancreatitis - Global Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering. This report provides most up-to-date ...
On Wednesday, 19 November 2025, Arrowhead Pharmaceuticals (NASDAQ:ARWR) presented at the Jefferies London Healthcare Conference 2025, unveiling a strategic outlook that balances recent successes with ...
For our Palisade phase III study in FCS patients, the pancreatitis events were adjudicated based on that. By the way, we did see a statistically significant improvement in pancreatitis risk when you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback